Subscribe
Low- vs High-Intensity Walking for PAD, Celecoxib for Stage III CRC, N95 Reprocessing Review, and more

JAMA Editor’s Summary

Low- vs High-Intensity Walking for PAD, Celecoxib for Stage III CRC, N95 Reprocessing Review, and more

Editor's Summary by Gregory Curfman, MD, Deputy Editor of JAMA, the Journal of the American Medical Association, for the
April 6, 2021
ADVERTISEMENT
WP Engine Wordpress Hosting

Low- vs High-Intensity Walking for PAD, Celecoxib for Stage III CRC, N95 Reprocessing Review, and more

Editor’s Summary by Gregory Curfman, MD, Deputy Editor of JAMA, the Journal of the American Medical Association, for the April 6, 2021 issue

ADVERTISEMENT
WP Engine Wordpress Hosting

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Proudly supported by:

cover
Javier Lozano - Market-Creating Innovation for Diabetes Care an inspiring conversation with Javier Lozano, Founder and CEO of Clínicas del Azúcar, a growing chain of "one-stop shops" for diabetes care in Mexico.